Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Surg.

Sec. Reconstructive and Plastic Surgery

Volume 12 - 2025 | doi: 10.3389/fsurg.2025.1636822

Madelung's disease -A Case Series from a Single-Center Experience

Provisionally accepted
Monika  ŁąckaMonika Łącka1,2Julia  WojciechowskaJulia Wojciechowska1,3Paulina  BerneckaPaulina Bernecka1*Hanna  SzóstekHanna Szóstek1Amelia  StolpAmelia Stolp1Zuzanna  ZieniewiczZuzanna Zieniewicz1Martyna  MillerMartyna Miller1Brygida  OssowskaBrygida Ossowska1Jerzy  JankauJerzy Jankau1,2
  • 1Faculty of Medicine, Medical University of Gdansk, Gdańsk, Poland
  • 2University Clinical Center in Gdańsk, Department of Plastic Surgery, Gdańsk, Poland
  • 3Division of Embryology, Department of Anatomy, Medical University of Gdansk, Gdańsk, Poland

The final, formatted version of the article will be published soon.

Introduction: Madelung's disease (MD), also known as multiple symmetric lipomatosis, is a rare metabolic disorder characterized by the accumulation of unencapsulated adipose tissue, predominantly in the head, neck, and upper trunk. Non-surgical treatment options remain limited in effectiveness, making surgical excision the primary therapeutic approach. However, challenges such as intraoperative bleeding and postoperative recurrence necessitate ongoing refinement of surgical techniques. Methods: We conducted a retrospective case series involving six patients diagnosed with Madelung's disease and treated surgically between 2018 and 2024 at the Department of Plastic Surgery, University Clinical Hospital in Gdańsk. All patients underwent staged surgical excision of pathological adipose tissue following infiltration with Klein's solution to minimize bleeding. Demographic and clinical data, comorbidities, fat distribution patterns (Type I or II), and body mass index (BMI) were recorded. The primary outcome was recurrence in the operated regions over a one-year follow-up period; the secondary outcome was the occurrence of surgical complications. Results: The study included five male and one female patient, with a mean age of 57 years (range: 44–67). Risk factors included smoking (n=4), alcohol abuse (n=2), and metabolic or systemic comorbidities. The BMI ranged from 21 to 33. All patients underwent successful surgical resection, with no recurrence of adipose tissue in the treated areas during follow-up. Histopathological evaluation confirmed the presence of benign lipomas in all specimens. No major complications, such as excessive bleeding or postoperative infections, were observed. Discussion: Surgical excision with prior infiltration of Klein's solution appears to be a safe and effective treatment for Madelung's disease, offering low recurrence and complication rates. The use of staged procedures and careful intraoperative management is critical in addressing the disease's vascular and infiltrative nature. While these findings are promising, larger prospective studies are needed to validate the efficacy of this approach and to further optimize surgical strategies for this rare condition.

Keywords: Madelung's disease, Madelung's disease treatment, Multiple symmetric lipomatosis, surgical treatment, Klein's solution, Rare metabolic disorder

Received: 24 Jul 2025; Accepted: 15 Sep 2025.

Copyright: © 2025 Łącka, Wojciechowska, Bernecka, Szóstek, Stolp, Zieniewicz, Miller, Ossowska and Jankau. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Paulina Bernecka, pauline.bernecka@gmail.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.